Forex Today: Volatility returns with upbeat US data
|Here is what you need to know on Tuesday, November 24:
The dollar rallied on self-strength for the first time in months, following the release of better than expected growth-related figures. The greenback was under selling pressure on the back of risk-appetite ahead of the headlines, as investors were focused on coronavirus vaccination plans in the US and some European countries, who announce December/January as possible dates.
EUR/USD peaked at 1.1905 to later flirt with the 1.1800 figure, as EU data failed to impress. Manufacturing activity held within expansion levels in November, but services output plunged amid the latest coronavirus-related restrictions imposed in the region.
The Pound was among the strongest amid mounting hopes that a Brexit trade deal could be announced soon. EU’s chief negotiator Michel Barnier said that big differences persisted in trade talks but added that both sides were pushing hard for a deal, despite fundamental divergences still remain.
The US government is pushing for an informal alliance of Western nations to jointly retaliate against China. The idea came as Beijing is putting pressure on Australia after this last called for an investigation into the origins of the Covid-19 pandemic, banning imports from multiple goods produced in the country.
AstraZeneca reported that its coronavirus vaccine has up to 90% effectiveness in preventing coronavirus. Full data has yet to be released, although the headline provided support to high-yielding assets in the European session.
US indexes traded mixed throughout the session but got to post modest gains ahead of the close. The Dow Jones Industrial Average was the best performer.
Gold plunged to its lowest in four months, trading as low as $1,830 a troy ounce on the back of the resurgent dollar’s demand. Upbeat US data diminish chances of a large stimulus package, which also plays against the bright metal.
Cryptocurrencies Price Prediction: Ethereum, Litecoin & Yearn.Finance – American Wrap 23 November
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.